| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.097 | 0.04 |